DGI develops generic & premium off-patent medical devices eligible for FDA fast-track clearance, and uses a novel web-based sales approach.
Many proven off-patent medical devices are priced at unsustainable margins. DeviceGenerics will offer quality, low cost generic and premium alternative devices to hospitals and providers. Its initial target market is disposable perfusion products used in open heart surgery. DGI will first offer, under its "ePerfusion" brand, its generic and patent-pending cardioplegia delivery sets, as well as improved cannula, using a novel e-commerce model.